In the case of cancer, particularly gastric cancer, the role that TLR-9 plays in immunosurveillance and shaping the tumor microenvironment suggests that it may be a promising target for therapy and a useful prognostic marker [17,18]. This evidence concerns the gene TLR9 and gastric cancer.